Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Zanubrutinib (Brukinsa TM) is approved by the FDA and the EMA for adult patients with Waldenström’s macroglobulinemia (WM) without restriction to line of therapy (1, 3)
Zanubrutinib, the most recently FDA-approved therapy for WM, has demonstrated comparable efficacy regarding hematologic response, but with an improved side effect profile compared to other [BTK inhibitors](brain://oTYjibgK…